![David J. Lockhart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David J. Lockhart
No open positions remaining
Profile
David J.
Lockhart was the founder of Ambit Biosciences Corp., founded in 2001, where the title held was President & Chief Scientific Officer in 2005.
Former jobs include Director-Genomics at Novartis Institute for Functional Genomics, Inc. from 1999 to 2000, Director & Chief Scientific Officer at ReCode Therapeutics, Inc. from 2022 to 2025, Vice President-Genomics Research at Affymetrix, Inc., and Chief Scientific Officer at Amicus Therapeutics, Inc. from 2006 to 2013.
Education includes a doctorate from Stanford University conferred in 1990.
Former positions of David J. Lockhart
| Companies | Position | End |
|---|---|---|
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage genetic medicines company that develops therapeutics for genetically defined diseases | Chief Executive Officer | 11/01/2022 |
| AMICUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2013 |
| AMBIT BIOSCIENCES CORP | Founder | 01/07/2005 |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Corporate Officer/Principal | 01/07/2000 |
Transcriptx, Inc.
 Transcriptx, Inc. BiotechnologyHealth Technology Develops mRNA therapies intended to treat primary ciliary dyskinesia | Chief Executive Officer | - |
Training of David J. Lockhart
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage genetic medicines company that develops therapeutics for genetically defined diseases | Health Technology |
Transcriptx, Inc.
Transcriptx, Inc. BiotechnologyHealth Technology Develops mRNA therapies intended to treat primary ciliary dyskinesia | Health Technology |
- Stock Market
- Insiders
- David J. Lockhart
